[{"Assets_0_Q1_USD":"13218650000.0","CIK":"1593034","CommonStockSharesConverted_0_Q1_shares":"223103675.0","CommonStockSharesOutstanding_0_Q1_shares":"223103675.0","Country":"Ireland","EarningsPerShareBasic_1_Q1_USD":"-0.78","EarningsPerShareDiluted_1_Q1_USD":"-0.78","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"640358301.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"167763000.0","NetIncomeLossConverted_1_Q1_USD":"-173828000.0","OfficialName":"Endo International plc Ordinary Shares","RevenuesConverted_1_Q1_USD":"1037600000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":"2188053000.0","Ticker":"ENDP","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"223014000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"223014000.0","filed":"20170509","footnote":null,"form":"10-Q","fp":"Q1","fy":"2017.0","name":"ENDO INTERNATIONAL PLC","period":"20170331","qtrs":"0","uom":"USD"}]